Long-term health tracking for fatty liver disease
Part of Digestive system clinical trials.
This study tracks people with fatty liver disease over several years to see how their health changes. By joining, you help researchers understand the long-term effects of different types of liver disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have signed a consent form for a previous health study.
- You must be 18 years old or older.
- You must have been diagnosed with a fatty liver disease (MASLD, MetALD, or ALD).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
This research studies fatty liver disease linked to metabolic problems like diabetes and obesity. You'll wear a fitness tracker and have liver imaging to help doctors understand the disease and find new treatments.
This study looks at whether the natural chemicals made by your gut bacteria from the food you eat could affect liver fat and health. If you have MASLD (a fatty liver condition), researchers want to measure these gut-produced substances to better understand the disease.
This study follows people with fatty liver disease (NAFLD) and a related condition (NASH) to see how it changes over time. It may help researchers understand who is most likely to worsen and what patterns show up as the disease progresses.
Hear when a new Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.